Jefferies Highlights Bio-Rad Labs (BIO) as ddPCR Publications Surged in '20, Chart of the Week
Tweet Send to a Friend
Jefferies analyst Brandon Couillard reiterated a Buy rating and $660.00 price target on Bio-Rad Labs (NYSE: BIO) after checks indicate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
